Search results
You’ve covered your copayment; now brace yourself for the ‘facility fee’
Maine Morning Star via Yahoo News· 1 hour agoEven if you have health insurance, you might expect to be charged a copayment for some routine care,...
DEA’s Psychedelic-Outlawing Effort Attacked by Private Industry | The Legal Intelligencer
Law.com· 8 hours agoDespite the U.S. Food and Drug Administration’s (FDA) approval of depression treatment drug...
Biden’s Climate Emergency: Green Policies On Steroids?
Forbes· 21 hours agoAccording to a Bloomberg report last week, White House officials have renewed discussions about...
Mass. Sen. Warren, Dems, want DEA to bump cannabis from most dangerous drugs list
The Republican· 3 days agoIt might be perfectly legal for adult Bay State residents to purchase recreational cannabis from...
AP Trending SummaryBrief at 4:31 p.m. EDT
Traverse City Record-Eagle· 2 days agoSean “Diddy” Combs has pushed back against a woman’s lawsuit that accused him of sexual assault. Combs’ lawyers filed a motion Friday to dismiss some claims that were not under law when the ...
Lawmakers urge DEA to pick up the pace on marijuana scheduling review
Courthouse News Service· 4 days agoMembers of Congress on Wednesday once again pushed the U.S. Drug Enforcement Administration to...
Opinion | RFK Jr.'s surprising pivot on climate change should have Trump worried
MSNBC via Yahoo News· 5 days agoKennedy also has changed his tune on fracking, a drilling method for extracting natural gas or oil...
Mastercard: How To Spark a Revolution in Inclusion
Morningstar· 3 days agoSmart people and smart ideas are a dime a dozen, U.S. Commerce Secretary Gina Raimondo told an audience of, well, smart people with smart ideas in Washington ...
Is India an Autocracy?
The Atlantic· 3 days agoThe assault on expression, and on virtually every other mainstay of democracy, has become commonplace under Prime Minister Narendra Modi’s government,...
AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY
Morningstar· 3 days agoAmgen (NASDAQ:AMGN) today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a fully human monoclonal antibody ...